Drug Trial Radar · NCT06237452
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
852
Planned (sponsor's estimate)
Start
May 20, 2024
Primary completion
Jun 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Vedanta Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI).
Conditions
- Clostridium Difficile
- Clostridium Difficile Infections
- Clostridium Difficile Infection Recurrence
- Clostridioides Difficile Infection
- Clostridioides Difficile Infection Recurrence
- CDI
- C. Diff Infection
- Recurrent Clostridium Difficile Infection
- C.Difficile Diarrhea
- Diarrhea Infectious
Interventions
VE303Biological
VE303 is a live biotherapeutic product (LBP) consisting of 8 clonally derived, nonpathogenic, nontoxigenic, commensal bacteria strains manufactured under Good Manufacturing Practices (GMP) conditions.
PlaceboBiological
Placebo capsules contain microcrystalline cellulose. Placebo capsules are visually identical to and not discernible from VE303 capsules. Placebo capsules will not contain any VE303 drug product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CDI Recurrence Rate at Week 8Time frame: 8 weeks
Locations
215 sites in 24 countries. Site status is shown where the registry gives one.
Metro Infectious Disease Consultants
Huntsville, Alabama · Recruiting
Advanced Gastroenterology, P.C.
Chandler, Arizona · Withdrawn
Mayo Clinic Hospital
Phoenix, Arizona · Withdrawn
GI Alliance
Sun City, Arizona · Recruiting
Om Research, LLC
Apple Valley, California · Withdrawn
Science 37 Inc (Remote/Home option)
Culver City, California · Recruiting
Children's Hospital of Los Angeles
Los Angeles, California · Recruiting
VA San Diego Healthcare System
San Diego, California · Recruiting
North America Research Institute
San Dimas, California · Withdrawn
Clinical Trials Management Services
Thousand Oaks, California · Recruiting
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California · Recruiting
Connecticut Clinical Research Institute
Bristol, Connecticut · Recruiting
Medical Research Center of Connecticut
Hamden, Connecticut · Recruiting
Hartford Hospital
Hartford, Connecticut · Withdrawn
Gastro Florida
Clearwater, Florida · Recruiting
Proactive Clinical Research, LLC
Fort Lauderdale, Florida · Recruiting
Encore Borland-Groover Clinical Research
Jacksonville, Florida · Recruiting
GI Pros Research
Naples, Florida · Recruiting
Advanced Medical Research Center
Port Orange, Florida · Recruiting
KM International Research Operation LLC
Saint Cloud, Florida · Recruiting
James A. Haley Veterans' Hospital
Tampa, Florida · Recruiting
International Center for Research
Tampa, Florida · Recruiting
Summit Clinical Research, LLC
Athens, Georgia · Recruiting
Emory University Hospital Midtown
Atlanta, Georgia · Recruiting
Metro Infectious Disease Consultants
Decatur, Georgia · Recruiting
Regional Infectious Diseases and Infusion Center, Inc.
La Grange, Georgia · Withdrawn
Gastrointestinal Specialists of Georgia
Marietta, Georgia · Recruiting
Snake River Research, PLLC
Idaho Falls, Idaho · Recruiting
Metro Infectious Disease Consultants
Burr Ridge, Illinois · Recruiting
NorthShore University Health System - Evanston Hospital
Evanston, Illinois · Withdrawn
GI Alliance
Gurnee, Illinois · Recruiting
Innovative Clinical Research Center, LLC (ICRC)
Island Lake, Illinois · Withdrawn
Indiana University Health University Hospital
Indianapolis, Indiana · Recruiting
Gastroenterology Health Partners
New Albany, Indiana · Recruiting
Deaconess GI Specialty Center
Newburgh, Indiana · Withdrawn
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
IDC Clinical Research, LLC
Wichita, Kansas · Withdrawn
Gastroenterology Health Partners
Louisville, Kentucky · Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Terminated
Showing 40 of 215 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.